Intravenous immunoglobulin therapy for COVID-19 ARDS.

Wilfong, Erin M; Matthay, Michael A

Wilfong, Erin M; Matthay, Michael A.

Wilfong EM; Division of Rheumatology and Immunology and Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: erin.m.wilfong@vumc.org.
Matthay MA; Department of Medicine and Department of Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.

Lancet Respir Med ; 10(2): 123-125, 2022 02.

Article in English | MEDLINE | ID: covidwho-1751526

Subject(s)

COVID-19; Respiratory Distress Syndrome; Humans; Immunoglobulins, Intravenous; Respiration, Artificial; Respiratory Distress Syndrome/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google